Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Indigenous Land and Sea Management Programs (ILSMPs) Enhance the Wellbeing of Indigenous Australians.
Larson S, Stoeckl N, Jarvis D, Addison J, Grainger D, Watkin Lui F, Walalakoo Aboriginal Corporation, Bunuba Dawangarri Aboriginal Corporation Rntbc, Ewamian Aboriginal Corporation Rntbc, Yanunijarra Aboriginal Corporation Rntbc. Larson S, et al. Among authors: addison j. Int J Environ Res Public Health. 2019 Dec 23;17(1):125. doi: 10.3390/ijerph17010125. Int J Environ Res Public Health. 2019. PMID: 31878049 Free PMC article.
The role of refuges in the persistence of Australian dryland mammals.
Pavey CR, Addison J, Brandle R, Dickman CR, McDonald PJ, Moseby KE, Young LI. Pavey CR, et al. Among authors: addison j. Biol Rev Camb Philos Soc. 2017 May;92(2):647-664. doi: 10.1111/brv.12247. Epub 2015 Dec 21. Biol Rev Camb Philos Soc. 2017. PMID: 26685752 Review.
Application of the integrated threat theory to conservation law enforcement.
Soofi M, Ghasemi B, Ahmadpour M, Soufi M, Islami I, Eckert A, Arabi MHG, Qashqaei AT, Selyari J, Nasirahmadi K, Kamp J, Waltert M, Addison J, Pavey CR. Soofi M, et al. Among authors: addison j. Conserv Biol. 2024 Mar 13:e14248. doi: 10.1111/cobi.14248. Online ahead of print. Conserv Biol. 2024. PMID: 38477229
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial.
Leng X, Leszczyński P, Jeka S, Liu SY, Liu H, Miakisz M, Gu J, Kilasonia L, Stanislavchuk M, Yang X, Zhou Y, Dong Q, Rezk M, Mitroiu M, Addison J, Zeng X. Leng X, et al. Among authors: addison j. Lancet Rheumatol. 2024 Jan;6(1):e40-e50. doi: 10.1016/S2665-9913(23)00237-0. Lancet Rheumatol. 2024. PMID: 38258678 Clinical Trial.
209 results